Quantcast

Latest autoimmune diseases Stories

2014-07-29 16:26:15

Researchers Look to Target Gut Microbiome for Treatment and Prevention of Crohn's Disease and Ulcerative Colitis NEW YORK, July 29, 2014 /PRNewswire/ -- Early findings from a major research initiative of the Crohn's & Colitis Foundation of America (CCFA) suggest that specific bacteria play a central role in Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD). The evidence raises the possibility of developing new treatments to target the...

2014-07-24 04:21:22

NEW YORK, July 24, 2014 /PRNewswire/ -- Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company"), announced a collaboration to increase awareness of unmet needs in treating bullous pemphigoid last night at an event attended by more than sixty patients, physicians, scientists and other interested parties. Lyfebulb is a health and wellness company dedicated...

2014-07-23 08:27:58

What Will Your Challenge Be? NEW YORK, July 23, 2014 /PRNewswire/ -- The Crohn's & Colitis Foundation of America's endurance training and fundraising program, Team Challenge, is thrilled to unveil its upcoming race portfolio with 11 great endurance events scheduled this winter including: -- TriRock San Diego - September 21 -- IRONMAN Chattanooga - September 28 -- Chicago Marathon - October 14 (limited entries) -- New York Marathon - November 1 (limited entries) --...

2014-07-22 08:32:06

New product offers treatment to significant unmet medical need in supportive cancer care DALLAS and NEW YORK, July 22, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a developer of new products for oncology supportive care, announced today that it has received 510(K) marketing clearance from the U.S. Food and Drug Administration (FDA) for ProctiGard(TM), its novel treatment for symptomatic management of rectal mucositis. The Company indicated its development of...

2014-07-21 12:24:51

DANVERS, Mass., July 21, 2014 /PRNewswire/ -- The Scleroderma Foundation is preparing for 600 people from around the world to attend its National Patient Education Conference later this week in Southern California. This unique educational event will be held at the Anaheim Marriot Friday, July 25, through Sunday, July 27. The conference focuses on scleroderma, a mysterious, and sometimes fatal, autoimmune disease that causes a person's body to attack itself by creating too much...

2014-07-18 23:02:00

Annual conference provides groundbreaking approaches to treating patients with interrelated autoimmune conditions. Malvern, PA (PRWEB) July 18, 2014 The inaugural Interdisciplinary Autoimmune Summit (IAS) brought together more than 150 gastroenterologists, rheumatologists, dermatologists, immunologists, internists, industry, and other allied healthcare professionals at The Mirage, Las Vegas, NV, June 20-22, 2014. "IAS 2014 was a wonderful opportunity to meet and discuss best...

2014-07-18 08:25:11

Take Steps Walk Program Helps Fund Key Initiatives for CCFA NEW YORK, July 18, 2014 /PRNewswire-USNewswire/ -- High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and Microbiome Research Initiatives. It's fundraising...

2014-07-16 20:22:34

Local New York team is forming to prepare runners and walkers for the ultimate tour of Vegas NEW YORK, July 16, 2014 /PRNewswire/ -- The 6th annual Rock 'n 'Roll Las Vegas Marathon & 1/2 Marathon to benefit the Crohn's & Colitis Foundation of America (CCFA) is taking place on Sunday, November 16, 2014. "Team Challenge prepares participants to run or walk a half marathon while helping to raise necessary funds for research, education, and support for the 1.4 million Americans suffering...

2014-07-16 12:28:22

Bacteria and Genes in Small Intestine affect course of IBD in Children NEW YORK, July 16, 2014 /PRNewswire-USNewswire/ -- Specific types of bacteria and accompanying gene expression patterns in the small intestine affect the development and progression of inflammatory bowel (IBD) diseases in children, according to research sponsored by the Crohn's & Colitis Foundation of America (CCFA). The identification of specific bacterial populations and a core gene signature associated...

2014-07-16 08:28:17

PORTLAND, Ore., July 16, 2014 /PRNewswire-USNewswire/ -- Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new treatments and a cure for psoriasis--an autoimmune disease that appears on the skin, affecting 7.5 million Americans--and psoriatic arthritis--an inflammatory arthritis that affects the joints and tendons, occurring in up to 30 percent of people with psoriasis. Learn more about the NPF research...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related